LiboniCristina Centre pour la Recherche en Biomedicine Strasbourg, INSERM U1109France

After successfully completing my PhD in Italy PhD on mesenchymal stromal cells and extracellular vesicles, I moved to Strasbourg (France) where I am dissecting the contribution of platelets to cancer and the impact of aging in cancer progression by exploiting murine tumor models, intravitral microscopy and tissue immunostainings.

Monday, 16 June 2025

Time	Session

10:30 12:00	Cancer Researchers to watch - An early career showcase (Separate pre-registration required) dos Santos DiasMatheus Chair The Netherlands Attaching to and Crossing Endothelial Barriers JacquemetGuillaume Speaker Finland Proffered Paper 7: CD24-mediated differential platelets-tumor cells binding tunes metastatic progression LiboniCristina Presenter France Proffered Paper 8: Microfluidic Single-Cell Profiling in Prostate Cancer Bone Metastasis Reveals Ultra-Migratory Subpopulations, Tumour-Bone Crosstalk and CTC Heterogeneity. CottonThomasDaniele Presenter United Kingdom Omomyc is a promising anti-MYC therapy for pediatric medulloblastoma EscuderoLaura Speaker Canada Auditorium VIII

Time

Session

10:30

12:00

Cancer Researchers to watch - An early career showcase

(Separate pre-registration required)

dos Santos DiasMatheus Chair The Netherlands

Attaching to and Crossing Endothelial Barriers

JacquemetGuillaume Speaker Finland
Proffered Paper 7: CD24-mediated differential platelets-tumor cells binding tunes metastatic progression

LiboniCristina Presenter France
Proffered Paper 8: Microfluidic Single-Cell Profiling in Prostate Cancer Bone Metastasis Reveals Ultra-Migratory Subpopulations, Tumour-Bone Crosstalk and CTC Heterogeneity.

CottonThomasDaniele Presenter United Kingdom
Omomyc is a promising anti-MYC therapy for pediatric medulloblastoma

EscuderoLaura Speaker Canada

Auditorium VIII